Brooks Laboratories (BROOKS) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
825.6M
Gross Profit
284.8M
34.50%
Operating Income
33.4M
4.04%
Net Income
-99.7M
-12.07%
EPS (Diluted)
-₹3.72
Balance Sheet Metrics
Total Assets
1.2B
Total Liabilities
255.9M
Shareholders Equity
981.0M
Debt to Equity
0.26
Cash Flow Metrics
Operating Cash Flow
-42.7M
Free Cash Flow
16.0M
Revenue & Profitability Trend
Brooks Laboratories Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 825.6M | 790.1M | 624.8M | 900.9M | 770.4M |
| Cost of Goods Sold | 540.7M | 610.6M | 612.2M | 758.0M | 552.4M |
| Gross Profit | 284.8M | 179.5M | 12.6M | 142.9M | 218.0M |
| Operating Expenses | 105.8M | 46.3M | 108.2M | 101.8M | 70.4M |
| Operating Income | 33.4M | 14.4M | -335.5M | -217.0M | -66.0M |
| Pre-tax Income | -97.9M | -195.7M | -383.7M | -239.0M | -89.9M |
| Income Tax | 1.8M | 259.0K | -73.2M | -45.9M | 103.8M |
| Net Income | -99.7M | -195.9M | -310.5M | -193.1M | -193.7M |
| EPS (Diluted) | -₹3.72 | -₹7.65 | -₹12.57 | -₹7.67 | -₹7.03 |
Income Statement Trend
Brooks Laboratories Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 338.8M | 310.5M | 276.1M | 611.8M | 473.6M |
| Non-Current Assets | 898.2M | 594.0M | 819.9M | 1.3B | 1.1B |
| Total Assets | 1.2B | 904.5M | 1.1B | 2.0B | 1.6B |
| Liabilities | |||||
| Current Liabilities | 228.4M | 230.5M | 330.2M | 488.8M | 636.1M |
| Non-Current Liabilities | 27.5M | 18.1M | 26.2M | 127.1M | 193.1M |
| Total Liabilities | 255.9M | 248.6M | 356.4M | 615.9M | 829.3M |
| Equity | |||||
| Total Shareholders Equity | 981.0M | 655.9M | 739.5M | 1.3B | 791.5M |
Balance Sheet Composition
Brooks Laboratories Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -97.9M | -195.7M | -383.7M | -239.0M | -89.9M |
| Operating Cash Flow | -42.7M | -234.4M | -363.2M | -432.9M | -39.5M |
| Investing Activities | |||||
| Capital Expenditures | -9.1M | -4.4M | -4.7M | -203.1M | -56.1M |
| Investing Cash Flow | -460.4M | -4.4M | -4.7M | -250.0M | -53.0M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 425.0M | 112.7M | 176.3M | 744.2M | 1.0K |
| Free Cash Flow | 16.0M | -101.2M | -149.6M | -606.6M | -11.6M |
Cash Flow Trend
Brooks Laboratories Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-37.18
Forward P/E
23.81
Price to Book
3.81
Price to Sales
4.94
PEG Ratio
23.81
Profitability Ratios
Profit Margin
-12.07%
Operating Margin
4.94%
Return on Equity
-12.18%
Return on Assets
1.95%
Financial Health
Current Ratio
1.48
Debt to Equity
7.73
Beta
0.72
Per Share Data
EPS (TTM)
-₹3.72
Book Value per Share
₹36.34
Revenue per Share
₹30.81
Financial data is updated regularly. All figures are in the company's reporting currency.